IRON

Disc Medicine, Inc. IRON

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-59.53M

Quarter to Jun 30

Free cash flow

$-44.20M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$3.13B total
FMR LLC
$357.98M-12.4%
BlackRock, Inc.
$180.50M+8.5%
RA CAPITAL MANAGEMENT, L.P.
$179.21M0.0%
JPMORGAN CHASE & CO
$139.87M+36.8%
PRICE T ROWE ASSOCIATES INC /MD/
$137.17M+21.0%
WELLINGTON MANAGEMENT GROUP LLP
$127.36M+0.3%
STATE STREET CORP
$120.60M-2.9%
Vestal Point Capital, LP
$113.37M+121.4%
Atlas Venture Life Science Advisors, LLC
$110.72M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$100.13M-0.5%
Frazier Life Sciences Management, L.P.
$99.09M0.0%
TCG Crossover Management, LLC
$98.14M0.0%
BVF INC/IL
$84.38M-9.3%
Woodline Partners LP
$70.09M0.0%
Siren, L.L.C.
$64.98M-10.1%
Logos Global Management LP
$64.00M+56.2%
Opaleye Management Inc.
$62.53M+103.1%
GEODE CAPITAL MANAGEMENT, LLC
$57.77M+6.1%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$48.05M0.0%
DIMENSIONAL FUND ADVISORS LP
$41.62M+44.3%
Bellevue Group AG
$40.96M+21.9%
Saturn V Capital Management LP
$38.38M+16.6%
ARMISTICE CAPITAL, LLC
$33.64M-14.2%
JENNISON ASSOCIATES LLC
$32.15M-28.0%
abrdn plc
$32.05M+16.7%
See all 218 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/IRON

Earnings Per Share

13fpro.ai/company/IRON

Loading ratio trend…

IRON insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Disc Medicine, Inc. (IRON): stock profile, AI score and financials

Disc Medicine, Inc. (IRON) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. IRON is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Disc Medicine, Inc. reports net income of $-59.5M, free cash flow of $-44.2M. Top institutional holders of IRON by reported 13-F value include FMR, BlackRock, RA CAPITAL MANAGEMENT, L.P., based on the most recent SEC filings. IRON trades on the Nasdaq exchange and files with the SEC under CIK 1816736. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IRON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Disc Medicine, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1816736 →